Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Takeda-Orifarm deal: another divestiture for the Japanese pharma giant

In keeping with its long-term business strategy, Japanese pharma giant Takeda has divested 110 over-the-counter and prescription pharma products to Orifarm. The $670m deal is the latter’s largest acquisition to date and support the future growth of the company.

Close
Close
Close

Go Top